Pharmacokinetics and pharmacodynamics of a recombinant fusion protein linking activated coagulation factor VII with human albumin (rVIIa-FP) in patients with congenital FVII deficiency.

Conclusion: These results warrant further investigation into the efficacy of rVIIa-FP to control and prevent bleeding in patients with FVII deficiency.
PMID: 31852380 [PubMed - in process]

Source: Hematology - December 21, 2019 Category: Hematology Tags: Hematology Source Type: research